Mereo BioPharma Group plc Notification of Director Dealing (7956P)
14 Outubro 2019 - 8:21AM
UK Regulatory
TIDMMPH
RNS Number : 7956P
Mereo BioPharma Group plc
14 October 2019
Mereo BioPharma Group plc
("Mereo" or the "Company")
Notification of Director Dealing
London, October 14, 2019 - Mereo BioPharma Group plc (AIM: MPH,
NASDAQ: MREO), a clinical stage UK based biopharmaceutical company
focused on rare diseases, received notification that on October 11,
2019, Peter Fellner, Chairman of the Board of Directors of Mereo,
purchased 23,800 Ordinary Shares at a price of GBP0.60 per share.
On the same day, Peter Fellner also purchased 1,700 Ordinary Shares
at a price of GBP0.61 per share.
The below announcement and notification is made in accordance
with the EU Market Abuse Regulation. The form required under the EU
Market Abuse Regulation follows.
1 Details of the person discharging managerial responsibilities
a) Name Peter Fellner
------------------------ ------------------------------------------
2 Reason for the notification
--------------------------------------------------------------------
a) Position/status Chairman of the Board of Directors
------------------------ ------------------------------------------
b) Initial notification/ Initial notification
Amendment
------------------------ ------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------
a) Name Mereo BioPharma Group plc
------------------------ ------------------------------------------
b) LEI 213800U8JQHIJOS5AS09
------------------------ ------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
--------------------------------------------------------------------
a) Description of MEREO BIOPHARMA GROUP PLC ORDINARY SHARES
the financial
instrument, type
of instrument
and identification
code
------------------------ ------------------------------------------
b) Nature of the PURCHASE
transaction
------------------------ ------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) GBP0.60 23800
----------
------------------------ ------------------------------------------
d) Aggregated information: Aggregated volume: 23800
volume, Price Aggregated price: GBP0.60
------------------------ ------------------------------------------
e) Date of the transaction 2019-10-11
------------------------ ------------------------------------------
f) Place of the AIMX
transaction
------------------------ ------------------------------------------
1 Details of the person discharging managerial responsibilities
a) Name Peter Fellner
------------------------ ------------------------------------------
2 Reason for the notification
--------------------------------------------------------------------
a) Position/status Chairman of the Board of Directors
------------------------ ------------------------------------------
b) Initial notification/ Initial notification
Amendment
------------------------ ------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------
a) Name Mereo BioPharma Group plc
------------------------ ------------------------------------------
b) LEI 213800U8JQHIJOS5AS09
------------------------ ------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
--------------------------------------------------------------------
a) Description of MEREO BIOPHARMA GROUP PLC ORDINARY SHARES
the financial
instrument, type
of instrument
and identification
code
------------------------ ------------------------------------------
b) Nature of the AIMX
transaction
------------------------ ------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) GBP0.61 1700
----------
------------------------ ------------------------------------------
d) Aggregated information: Aggregated volume: 1700
volume, Price Aggregated price: GBP0.61
------------------------ ------------------------------------------
e) Date of the transaction 2019-10-11
------------------------ ------------------------------------------
f) Place of the AIMX
transaction
------------------------ ------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHUSAARKKARAAA
(END) Dow Jones Newswires
October 14, 2019 07:21 ET (11:21 GMT)
Mereo Biopharma (LSE:MPH)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Mereo Biopharma (LSE:MPH)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025
